# Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions

> **NCT01149980** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Citalopram Hydrobromide

## Key facts

- **NCT ID:** NCT01149980
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2010-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01149980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01149980, "Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01149980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*